Brief: Mission Bio Partners With Fulgent Genetics To Broaden Accessibility Of Single-Cell Multi-Omics
11/04/2023 13:19
April 11 (Reuters) - Fulgent Genetics Inc FLGT.O :
* MISSION BIO PARTNERS WITH FULGENT GENETICS TO BROADEN
ACCESSIBILITY OF SINGLE-CELL MULTI-OMICS FOR DRUG DEVELOPMENT
AND CLINICAL RESEARCH
Source text for Eikon: ID:nPn7FbKXja
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview